NIAID -- Genomic Centers for Infectious Diseases (U19 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The purpose of this initiative is to support Genomic Centers for Infectious Diseases (GCID) to promote broad use and expand the application of genomics technologies and computational analysis to understand infectious diseases, with an emphasis on pathogens, their interaction with the host and microbiome, and to aid in the development of novel genomics-based tools to diagnose, prevent and treat infectious diseases. The GCID will support innovative technology development in all aspects of genomics, including the use of synthetic and genome editing technologies as well as functional genomics to address basic, translational, and clinically relevant questions in host-pathogen interactions. The knowledge generated, including research data, analytical software tools, computational models, experimental protocols, and reagents, is expected to be widely disseminated to the scientific community through publicly accessible databases and reagent repositories.


  • Letters of Intent Due Date(s):  May 22, 2018
  • Application Due Dates(s):  June 22, 2018

RFA-AI-18-004 Expiration Date: June 23, 2018

Agency Website

Amount Description

Applicants may propose budgets of up to $3.75 million direct costs per year, which includes up to $75,000 in direct costs for either one or a maximum of two Collaborative Pilot Projects per year. Application budgets need to reflect the actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum period is 5 years. 

Funding Type





Engineering and Physical Sciences
Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

June 22, 2018